Mesenchymal Cell News Volume 14.05 | Feb 8 2022

    0
    18







    2022-02-08 | MESCN 14.05


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.05 – 8 February, 2022
    TOP STORY

    In Vivo Tracking of Unlabelled Mesenchymal Stromal Cells by Mannose-Weighted Chemical Exchange Saturation Transfer MRI

    The authors showed that high-mannose N-linked glycans could serve as a biomarker for the label-free tracking of transplanted human MSCs by mannose-weighted chemical exchange saturation transfer magnetic resonance imaging.
    [Nature Biomedical Engineering]

    Abstract

    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    PUBLICATIONSRanked by the impact factor of the journal

    A Neomorphic Variant in SP7 Alters Sequence Specificity and Causes a High-Turnover Bone Disorder

    Scientists described a de novo dominant neomorphic missense variant in SP7 in a patient with craniosynostosis, cranial hyperostosis, and long bone fragility. Histomorphometry showed increased osteoblasts but decreased bone mineralization.
    [Nature Communications]

    Full Article

    Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

    Researchers characterized changes in the soft tissue sarcoma tumor immune microenvironment induced by standard neoadjuvant therapy with the goal of informing neoadjuvant immunotherapy trial design.
    [Clinical Cancer Research]

    Abstract

    M6A Demethylase FTO-Mediated Downregulation of DACT1 mRNA Stability Promotes Wnt Signaling to Facilitate Osteosarcoma Progression

    Functional screening showed that the N6-methyladenosine (M6A) demethylase FTO could be a candidate therapeutic target for osteosarcoma (OS). FTO promoted the growth and metastasis of OS in vitro and in vivo.
    [Oncogene]

    Abstract

    Collagenase Treatment Appears to Improve Cartilage Tissue Integration but Damage to Collagen Networks Is Likely Permanent

    Investigators used engineered cartilage microtissues formed from bone marrow-derived stromal cells or expanded articular chondrocytes to study the impact of enzyme treatment on cartilage tissue integration and matrix remodeling.
    [Journal of Tissue Engineering]

    Full Article

    ECM1 Modified HF-MSCs Targeting HSC Attenuate Liver Cirrhosis by Inhibiting the TGF-β/Smad Signaling Pathway

    To improve the effectiveness of naïve hair follicle-derived-MSC (HF-MSC) treatments on liver cirrhosis (LC), the authors used bioinformatic tools to identify an exogenous gene targeting hepatic stellate cells (HSCs) among the differentially expressed genes in LC to modify HF-MSCs.
    [Cell Death Discovery]

    Full Article

    Control of Stem Cell Differentiation by Using Extrinsic Photobiomodulation in Conjunction with Cell Adhesion Pattern

    Scientists demonstrated that the combination of extrinsic photobiomodulation and collagen-covered microislands could be used to induce differentiation of Wharton’s jelly MSCs with the differentiation direction dictated by the specific island topography without use of chemical factors.
    [Scientific Reports]

    Full Article

    Complement C5aR/LPS-Induced BDNF and NGF Modulation in Human Dental Pulp Stem Cells

    Researchers compared the neurogenic ability of dental pulp stem cells to bone marrow-derived MSCs under inflammatory stimulation.
    [Scientific Reports]

    Full Article

    Engineer a Pre-Metastatic Niched Microenvironment to Attract Breast Cancer Cells by Utilizing a 3D Printed Polycaprolactone/Nano-Hydroxyapatite Osteogenic Scaffold – an In Vitro Model System for Proof of Concept

    A transwell migration assay was used to investigate recruitment of MDA-MB-231, MCF-7, and MDA-MB-453 breast cancer cells to the osseous polycaprolactone-nano-hydroxyapatite scaffolds.
    [Journal of Biomedical Materials Research Part B-Applied Biomaterials]

    Abstract

    Sirtuin-1 – Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis Is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke

    The authors unveiled the role of MSCs in regulating the brain sirtuin-1 (SIRT-1) levels following stroke and the involvement of SIRT-1 in regulating inflammasome signaling to reduce cellular apoptosis towards rendering neuroprotection.
    [Stem Cell Reviews and Reports]

    Abstract

    The Application of Pulp Tissue Derived-Exosomes in Pulp Regeneration: A Novel Cell-Homing Approach

    Exosomes were isolated from the dental pulp tissue and dental pulp stem cells of swine. The effects of the exosomes on apical dental papilla were compared using CKK-8, Transwell, angiogenesis, and odontogenic induction assays.
    [International Journal of Nanomedicine]

    Full Article

    NEAT1 in Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Promotes Melanoma by Inducing M2 Macrophage Polarization

    Investigators demonstrated that bone marrow MSC-derived extracellular vesicles carrying NEAT1 could promote the progression of melanoma by inducing M2 polarization of macrophages, and thus might be considered as a potential target for melanoma therapeutics.
    [Cancer Gene Therapy]

    Abstract

    Exosomal microRNA-133b-3p from Bone Marrow Mesenchymal Stem Cells Inhibits Angiogenesis and Oxidative Stress via FBN1 Repression in Diabetic Retinopathy

    Researchers elucidated that exosomal miR-133b-3p from bone marrow MSCs suppressed angiogenesis and oxidative stress in diabetic retinopathy via FBN1 repression.
    [Gene Therapy]

    Abstract

    Latest updates and debates on mesenchymal stem cells.
    REVIEWS

    Mesenchymal Stem Cell-Derived Extracellular Vesicles: The Novel Therapeutic Option for Regenerative Dentistry

    The authors summarize the types of MSCs that could be potentially applied in regenerative dentistry, the possible molecular cargos of MSC-extracellular vesicles (EVs), and the major effects of MSC-EVs on the therapeutic induction of osteogenic differentiation.
    [Stem Cell Reviews and Reports]

    AbstractGraphical Abstract

    Clinical Efficacy and Mechanism of Mesenchymal Stromal Cells in Treatment of COVID-19

    Scientists summarize the clinical efficacy of MSCs in the treatment of COVID-19 based on published results, including mortality, time to symptom improvement, computed tomography imaging, cytokines, and safety, while elaborating on the possible mechanisms underpinning the effects of MSCs.
    [Stem Cell Research & Therapy]

    Full Article

    Platelet-Derived Respiratory-Competent Mitochondria Transfer to Mesenchymal Stem Cells to Promote Wound Healing via Metabolic Reprogramming

    Investigators discuss the mechanisms of platelet mitochondrial translocation and metabolic reprogramming of MSCs, suggesting that platelets or platelet-containing preparations such as platelet-rich plasma may provide a practical guide for tissue injury treatment.
    [Platelets]

    Abstract

    INDUSTRY AND POLICY NEWS

    Calidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies

    Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company developing cell-based delivery of oncolytic viruses, and Edoc Acquisition Corp. have entered into a definitive merger agreement.
    [Calidi Biotherapeutics, Inc.]

    Press Release

    BioRestorative Therapies Announces It Has Initiated Its Phase II Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway

    BioRestorative Therapies, Inc. announced that it has initiated the site selection process for its active Phase II clinical trial targeting chronic lumbar disc disease with BRTX-100, a product formulated from autologous cultured MSCs collected from the patient’s bone marrow.
    [BioRestorative Therapies, Inc. (Globe Newswire, Inc.)]

    Press Release

    FEATURED EVENT

    ISCT ANZ – BAA Joint Scientific Meeting

    February 24 – February 25, 2022
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Fellow – Tumor Metabolism

    Wayne State University School of Medicine – Detroit, Michigan, United States

    Postdoctoral Position – Regenerative Medicine

    Stanford University – Stanford, California, United States

    PhD Scholarship – Tissue Engineering & Scaffold Design

    Nanyang Technological University – Singapore, Singapore

    Postdoctoral Fellow – Regenerative Medicine

    National University of Ireland Galway – Galway, Ireland

    Postdoctoral Fellowships – Extracellular Vesicles, Microglia and Alzheimer’s Disease

    Mayo Clinic Florida Campus – Jacksonville, Florida, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter